Skip to main content
. 2022 Dec 7;13:997023. doi: 10.3389/fendo.2022.997023

Table 1.

Baseline characteristics of the case group and control group.

Variables Control group N = 623 Case group N = 180 P-value
Age (years) 58.0 (49.0; 68.0] 59.0 (51.0; 69.2] 0.314
Sex (n, %) 0.161
 Male 363 (58.3%) 116 (64.4%)
 Female 260 (41.7%) 64 (35.6%)
Smoking (n, %) 0.351
 Never 425 (68.2%) 130 (72.2%)
 Former or current 198 (31.8%) 50 (27.8%)
Alcohol consumption status (n, %) 0.483
 Never 470 (75.4%) 141 (78.3%)
 Former or current 153 (24.6%) 39 (21.7%)
Diabetes mellitus (n, %) 1.000
 No 318 (51.0%) 92 (51.1%)
 Yes 305 (49.0%) 88 (48.9%)
CAD (n, %) 0.075
 No 504 (80.9%) 134 (74.4%)
 Yes 119 (19.1%) 46 (25.6%)
Hypertension (n, %) 0.919
 No 134 (21.5%) 40 (22.2%)
 Yes 489 (78.5%) 140 (77.8%)
SBP (mmHg) 139 (125; 151) 145 (126; 156) 0.047
DBP (mmHg) 83.0 (75.0; 93.0) 84.5 (76.0; 95.0) 0.309
BMI (kg/m2) 26.2 (24.4; 29.7) 27.2 (25.4; 31.3) 0.003
Heart rate (beats/min) 80.0 (77.0; 84.0) 80.0 (76.0; 84.0) 0.877
ALT (U/L) 20.0 (14.9; 29.3) 19.0 (14.0; 29.1) 0.604
AST (U/L) 18.0 (15.0; 24.0) 19.0 (14.0; 24.0) 0.980
γ-GGT (U/L) 23.0 (16.1; 38.0) 25.0 (17.8; 39.2) 0.232
ALP (U/L) 70.2 (60.1; 89.7) 74.6 (66.1; 95.2) 0.008
Albumin (g/L) 40.6 (37.2; 44.3) 39.5 (36.3; 42.8) 0.021
Cr (umol/L) 60.9 (51.9; 73.8) 62.4 (49.7; 76.4) 0.645
BUN (mmol/L) 2.31 (0.08; 5.17) 0.16 (0.08; 4.93) 0.562
UA (umol/L) 301 (244; 372) 299 (247; 374) 0.834
TG (mmol/L) 1.35 (1.08; 2.08) 1.34 (1.18; 1.89) 0.744
LDL-C (mmol/L) 2.58 (2.02; 3.14) 2.58 (1.97; 3.11) 0.574
TC (mmol/L) 4.37 (3.81; 5.08) 4.37 (3.55; 4.90) 0.097
HDL-C (mmoL/L) 1.05 (0.90;1.20) 1.01 (0.82;1.09) 0.002
Serum calcium (mmol/L) 2.22 (2.12; 2.31) 2.23 (2.13; 2.32) 0.417
Serum potassium (mmol/L) 3.87 (3.58; 4.14) 3.82 (3.58; 4.07) 0.134
Serum natrium (mmol/L) 140 (138; 142) 141 (138; 142) 0.158
Serum phosphate (mmol/L) 1.16 (1.01; 1.28) 1.17 (1.05; 1.32) 0.113
FBG (mmol/L) 5.08 (4.66; 7.20) 5.09 (4.62; 7.18) 0.834
CK (U/L) 67.0 (52.6; 106) 70.0 (59.6; 102) 0.501
CK-MB (ng/mL) 11.1 (1.52; 16.4) 12.1 (1.87; 16.4) 0.398
WBC (109/L) 6.55 (5.48; 8.09) 6.45 (5.26; 7.96) 0.538
PLT (109/L) 240 (199; 281) 241 (183; 288) 0.727
Hb (g/L) 139 (126; 151) 138 (124; 150) 0.738
D-Dimer (mg/L) 0.38 (0.23; 0.69) 0.43 (0.24; 0.80) 0.193
CortisoL (µg/dL) 8.39 (3.79; 14.3) 8.40 (4.93; 14.0) 0.194
ACTH (pg/mL) 18.6 (13.3; 30.6) 18.6 (12.7; 32.4) 0.953
TSH (µIU/mL) 2.11 (1.19; 3.18) 2.13 (1.09; 2.89) 0.295
FT3 (pg/mL) 2.73 (2.17; 3.02) 2.74 (2.25; 3.04) 0.447
FT4 (ng/dL) 1.16 (1.01; 1.33) 1.17 (1.02; 1.33) 0.381
TT3 (ng/mL) 0.92 (0.72; 1.08) 0.94 (0.74; 1.07) 0.423
TT4 (µg/dL) 6.70 (5.57; 8.02) 6.81 (5.87; 7.82) 0.493
IGF-1 (ng/mL) 122 (87.6; 161) 132 (95.3; 212) 0.001
GH (ug/L) 0.18 (0.09; 0.56) 0.36 (0.12; 1.37) <0.001
ACEI/ARB (n, %) 0.077
 No 469 (75.3%) 123 (68.3%)
 Yes 154 (24.7%) 57 (31.7%)
β blockers (n, %) 0.271
 No 554 (88.9%) 154 (85.6%)
 Yes 69 (11.1%) 26 (14.4%)
Calcium channel blockers (n, %) 0.354
 No 470 (75.4%) 129 (71.7%)
 Yes 153 (24.6%) 51 (28.3%)
Diuretics (n, %) 0.401
 No 553 (88.8%) 155 (86.1%)
 Yes 70 (11.2%) 25 (13.9%)
Antiplatelet agents (n, %) 0.788
 No 513 (82.3%) 146 (81.1%)
 Yes 110 (17.7%) 34 (18.9%)
Statin (n, %) 0.165
 No 537 (86.2%) 147 (81.7%)
 Yes 86 (13.8%) 33 (18.3%)

SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; CAD, coronary artery disease; DM, diabetes mellitus; ALT, alanine transaminase; AST, aspartate transaminase; γ-GGT, γ-gamma-glutamyltransferase; ALP, alkaline phosphatase; Cr, creatinine; BUN, blood urea nitrogen; UA, uric acid; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; CK, creatine kinase; CK-MB, creatine kinase isoenzyme MB; WBC, white blood cell; PLT, plastocyte; Hb, hemoglobin; ACTH, adrenalotropic hormone; TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, free thyroxine; TT3, total triiodothyronine; TT4, total thyroxine; IGF-1, insulin-like growth hormone-1; GH, growth hormone ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin 2 receptor blocker.